Obesity is an established risk factor for several human cancers. Given the association
between excess body weight and cancer, the increasing rates of obesity worldwide are …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal
cancers worldwide, with a poor prognosis and an increasing incidence. Recently, the tumor …

Beta adrenoblockers are a large class of drugs used to treat cardiovascular diseases,
migraines, glaucoma and hyperthyroidism. Over the last couple of decades, the anticancer …

Low responsiveness to chemotherapy is an important cause of poor prognosis in pancreatic
cancer. Smoking is a high‐risk factor for pancreatic cancer and cancer resistance to …

Chronic stress activates the sympathetic nervous system (SNS) and hypothalamic–pituitary–
adrenal (HPA) axis to aggravates tumorigenesis and development. Although the importance …

Preclinical and early clinical mechanistic studies of antitumor activity from the beta-
adrenergic receptor (β-AR) blocker propranolol have revealed both cell signaling and …

The incidence of prostate cancer in the world is increasing every year. Death caused by
prostate cancer is increased by 13% in men between 1980 and 2005. It is the second …

In this review, we aim to update readers about the most recent studies on common
pharmaceuticals and their association with pancreatic cancer risk. The use of prophylactic …

Objective Preclinical and in vitro studies have shown that beta blockade affect colorectal
cancer growth and metastasis through the sympathetic nervous system. There is no …

Four undescribed seco-polyprenylated acylphloroglucinols (seco-PAPs), elodeoidesones
AD (1–4), were characterized from Hypericum elodeoides. Compound 1 represents the 1, 6 …